Ho Wah Genting Berhad Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Ho Wah Genting Berhad te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Electrical winstgroei	31.2%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Jul 25

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Jun 18

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Dec 06

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Oct 05

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Jul 08

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Ho Wah Genting Berhad onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

KLSE:HWGB - Toekomstschattingen van analisten en financiële gegevens uit het verleden (MYR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2024	323	-2	10	10	N/A
6/30/2024	319	2	17	19	N/A
3/31/2024	272	2	3	5	N/A
12/31/2023	255	1	-8	-6	N/A
12/31/2022	418	-1	31	33	N/A
10/31/2022	464	1	43	45	N/A
7/31/2022	476	-2	-7	-4	N/A
4/30/2022	451	-5	-17	-14	N/A
4/30/2021	294	-24	-24	-22	N/A
9/30/2020	232	-7	5	7	N/A
6/30/2020	183	-7	4	5	N/A
3/31/2020	192	-5	-4	-3	N/A
12/31/2019	181	-7	8	10	N/A
9/30/2019	185	-31	6	7	N/A
6/30/2019	182	-32	-1	0	N/A
3/31/2019	157	-31	-2	-1	N/A
12/31/2018	160	-33	-10	-8	N/A
9/30/2018	163	-12	-11	-9	N/A
6/30/2018	162	-11	N/A	-4	N/A
3/31/2018	162	-12	N/A	7	N/A
12/31/2017	157	-11	N/A	3	N/A
9/30/2017	149	-10	N/A	4	N/A
6/30/2017	149	-8	N/A	2	N/A
3/31/2017	150	-10	N/A	-22	N/A
12/31/2016	148	-14	N/A	-20	N/A
9/30/2016	156	-11	N/A	-25	N/A
6/30/2016	166	-16	N/A	-14	N/A
3/31/2016	172	-18	N/A	9	N/A
12/31/2015	189	-16	N/A	10	N/A
9/30/2015	186	-23	N/A	14	N/A
6/30/2015	189	-20	N/A	5	N/A
3/31/2015	196	-18	N/A	8	N/A
12/31/2014	191	-22	N/A	3	N/A
9/30/2014	198	-25	N/A	1	N/A
6/30/2014	208	-27	N/A	-5	N/A
3/31/2014	225	-27	N/A	-9	N/A
12/31/2013	229	-24	N/A	-3	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van HWGB boven de spaarquote ( 3.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van HWGB naar verwachting sneller zal groeien dan de markt MY

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van HWGB naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van HWGB naar verwachting sneller zal groeien dan de markt MY.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van HWGB naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van HWGB naar verwachting over 3 jaar hoog zal zijn

Ho Wah Genting Berhad Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Third quarter 2024 earnings released: RM0.001 loss per share (vs RM0.014 loss in 3Q 2023)

New major risk - Market cap size

New major risk - Market cap size

Second quarter 2024 earnings released: EPS: RM0.006 (vs RM0.036 loss in 2Q 2023)

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Ho Wah Genting Berhad Appoints Madam Lim Ean Chin as Independent and Non Executive Director

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

First quarter 2024 earnings released: RM0.001 loss per share (vs RM0.036 loss in 1Q 2023)

Ho Wah Genting Berhad Announces the Resignation of Elaine Tan Ai Lin as Independent and Non Executive Chairman of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.007 (vs RM0.01 loss in FY 2022)

New major risk - Market cap size

New minor risk - Financial data availability

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

New major risk - Market cap size

New minor risk - Shareholder dilution

Many Still Looking Away From Ho Wah Genting Berhad (KLSE:HWGB)

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Full year 2022 earnings released: RM0.003 loss per share (vs RM0.009 loss in FY 2021)

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.007 loss in 2Q 2022)

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad has completed a Follow-on Equity Offering in the amount of MYR 2.939792 million.

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad Update on Phase 4 United States Food and Drug Administration Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

New 90-day low: RM0.55

Full year 2020 earnings released: RM0.044 loss per share (vs RM0.019 loss in FY 2019)

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Ho Wah Genting Berhad Announces Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Receives Product Registration Approval for Astramern Astra H Capsule from NPRA for A Period Commencing 14 January 2021 to 14 January 2026

Ho Wah Genting Berhad Enters into Memorandum of Understanding with Chongqing ISIA Bio-Technology Co., Ltd (ISIA) to Manufacture and Produce in Vitro Diagnostic Products

New 90-day low: RM0.59

Ho Wah Genting Berhad Provides Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Announces Benjamin Leong Wye Hoong as Independent and Non Executive Director

New 90-day high: RM0.89

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Third quarter 2020 earnings released: RM0.002 loss per share

Ho Wah Genting Berhad Enters into Memorandum of Understanding with GNOSIS LABORATORIES (M) SDN BHD

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Ho Wah Genting Berhad Announces Appointment as the Authorized Sale Agent/ Distributor for the Covid-19 related products from Wuhan Easy Diagnosis Biomedicine Co.,Ltd

Ho Wah Genting Berhad Announces Resignation of Mr. Bernard Lim Soon Chiang as Independent and Non Executive Member of Remuneration Committee

Ho Wah Genting Berhad Announces Redesignation of Mr. Kenny Yeoh Khi Khen from Independent and Non Executive Member of Risk Committee to Chairman of Risk Committee

First half earnings released

Dato Lim Ooi Hong, Lim Wee Kiat and Datuk Teo Tiew, Executive Directors of Ho Wah Genting Berhad completed the acquisition of remaining 70.24% stake in Ho Wah Genting Berhad (KLSE:HWGB).

New 90-day high - RM0.60

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven